NCT01483833View on ClinicalTrials.gov

Efficacy Study of Iferanserin to Treat Hemorrhoids

PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions
Hemorrhoids
Interventions
DRUG

Iferanserin

Iferanserin 0.5% ointment applied intra-anally twice daily for 14 days

DRUG

Placebo

Placebo ointment applied intra-anally twice daily for 14 days

Trial Locations (1)

Unknown

Prof. Alexander Herold, MD, Mannheim

All Listed Sponsors
lead

Ventrus Biosciences, Inc

INDUSTRY

NCT01483833 - Efficacy Study of Iferanserin to Treat Hemorrhoids | Biotech Hunter | Biotech Hunter